Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Eccleston

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|May 25, 2023
Implementation, compliance, and pandemic legal obligationsMark Eccleston-Turner, Gian-Luca Burci, Jonathan Liberman, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 25, 2023
Equity in the Pandemic Treaty: Access and Benefit-Sharing as a Policy Device or a Rhetorical Device?Abbie-Rose Hampton, Mark Eccleston-Turner, Michelle Rourke, et al.
Lancet (London, England)|September 10, 2020
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine accessAlexandra L Phelan, Mark Eccleston-Turner, Michelle Rourke, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 6, 2021
The World Health Organization in Global Health LawBenjamin Mason Meier, Allyn Taylor, Mark Eccleston-Turner, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Rapid high-throughput method for investigating physiological regulation of neutrophil extracellular trap formationKieran Zukas, Justin Cayford, Finley Serneo, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
Academia Meets IndustryChristian Schäfer, Tobias Paprotka, Ellen Heitzer, et al.
Epigenomics|September 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editingNing Kang, Mark Eccleston, Pier-Luc Clermont, et al.
Clinical Epigenetics|October 10, 2015
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancerMonika Bauden, Dorian Pamart, Daniel Ansari, et al.
Scientific Reports|September 28, 2023
Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphomaPriscilla Van den Ackerveken, Alison Lobbens, Dorian Pamart, et al.
Lancet (London, England)|April 15, 2021
Problems with traffic light approaches to public health emergencies of international concernClare Wenham, Matthew Kavanagh, Alexandra Phelan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|May 25, 2023
Implementation, compliance, and pandemic legal obligationsMark Eccleston-Turner, Gian-Luca Burci, Jonathan Liberman, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|May 25, 2023
Equity in the Pandemic Treaty: Access and Benefit-Sharing as a Policy Device or a Rhetorical Device?Abbie-Rose Hampton, Mark Eccleston-Turner, Michelle Rourke, et al.
Lancet (London, England)|September 10, 2020
Legal agreements: barriers and enablers to global equitable COVID-19 vaccine accessAlexandra L Phelan, Mark Eccleston-Turner, Michelle Rourke, et al.
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 6, 2021
The World Health Organization in Global Health LawBenjamin Mason Meier, Allyn Taylor, Mark Eccleston-Turner, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2024
Rapid high-throughput method for investigating physiological regulation of neutrophil extracellular trap formationKieran Zukas, Justin Cayford, Finley Serneo, et al.
Advances in Experimental Medicine and Biology|October 19, 2016
Academia Meets IndustryChristian Schäfer, Tobias Paprotka, Ellen Heitzer, et al.
Epigenomics|September 17, 2020
EZH2 inhibition: a promising strategy to prevent cancer immune editingNing Kang, Mark Eccleston, Pier-Luc Clermont, et al.
Clinical Epigenetics|October 10, 2015
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancerMonika Bauden, Dorian Pamart, Daniel Ansari, et al.
Scientific Reports|September 28, 2023
Epigenetic profiles of elevated cell free circulating H3.1 nucleosomes as potential biomarkers for non-Hodgkin lymphomaPriscilla Van den Ackerveken, Alison Lobbens, Dorian Pamart, et al.
Lancet (London, England)|April 15, 2021
Problems with traffic light approaches to public health emergencies of international concernClare Wenham, Matthew Kavanagh, Alexandra Phelan, et al.
Pageof 3